Correlation Between Reata Pharmaceuticals and Annovis Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Reata Pharmaceuticals and Annovis Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reata Pharmaceuticals and Annovis Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reata Pharmaceuticals and Annovis Bio, you can compare the effects of market volatilities on Reata Pharmaceuticals and Annovis Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reata Pharmaceuticals with a short position of Annovis Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reata Pharmaceuticals and Annovis Bio.

Diversification Opportunities for Reata Pharmaceuticals and Annovis Bio

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Reata and Annovis is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Reata Pharmaceuticals and Annovis Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annovis Bio and Reata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reata Pharmaceuticals are associated (or correlated) with Annovis Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annovis Bio has no effect on the direction of Reata Pharmaceuticals i.e., Reata Pharmaceuticals and Annovis Bio go up and down completely randomly.

Pair Corralation between Reata Pharmaceuticals and Annovis Bio

If you would invest  10,967  in Reata Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of  0.00  from holding Reata Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

Reata Pharmaceuticals  vs.  Annovis Bio

 Performance 
       Timeline  
Reata Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Reata Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Reata Pharmaceuticals is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Annovis Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Annovis Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Reata Pharmaceuticals and Annovis Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Reata Pharmaceuticals and Annovis Bio

The main advantage of trading using opposite Reata Pharmaceuticals and Annovis Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reata Pharmaceuticals position performs unexpectedly, Annovis Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis Bio will offset losses from the drop in Annovis Bio's long position.
The idea behind Reata Pharmaceuticals and Annovis Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance